Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation

Stefano Lucreziotti1, Marco Centola1, Diego Salerno-Uriarte1

  • 1Cardiologia, Ospedale San Paolo, Dipartimento di Scienze della Salute, University of Milan, Italy.

Insights

Female patients undergoing primary percutaneous coronary intervention (PCI) face a higher risk of contrast-induced nephropathy (CIN). Lower ejection fraction and female gender predict CIN, while CIN and Mehran Risk Score predict mortality.

Area of Science:

  • Cardiology
  • Nephrology
  • Interventional Cardiology

Background:

  • Contrast-induced nephropathy (CIN) is a significant risk following primary percutaneous coronary intervention (PCI).
  • Female patients may experience higher rates of CIN and mortality post-PCI, but the role of gender is complex.
  • Understanding predictors of CIN and mortality is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the relationship between patient variables, including gender, and the incidence of CIN.
  • To identify predictors of long-term mortality after primary PCI.
  • To clarify the specific role of female gender in CIN development and outcomes.

Main Methods:

  • A single-center study involving 323 consecutive patients undergoing primary PCI.
  • CIN was defined as an increase in serum creatinine (≥25% or ≥0.5 mg/dl) within 3 days post-procedure.
  • An 18-month median follow-up was used to assess mortality.

Main Results:

  • CIN occurred in 25.0% of females versus 11.2% of males (p=0.003).
  • Reduced left ventricular ejection fraction (LVEF) and female gender independently predicted CIN.
  • CIN development and a Mehran Risk Score (MRS) ≥6 independently predicted long-term mortality.

Conclusions:

  • Female gender and reduced LVEF are associated with increased CIN risk after primary PCI.
  • The Mehran Risk Score and the development of CIN are predictors of long-term mortality.
  • These findings highlight key factors for risk stratification and management in patients undergoing primary PCI.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
558
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.2K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495